In Brief
Bacterial lipoproteins are Sdiacylglyceryl modified, surface anchored proteins, which play important roles at the host-pathogen interface. We use metabolic tagging, combined with inactivation of lipoprotein biosynthesis, to profile the Clostridium difficile lipoproteome, revealing a role for lipoproteins in transmission of this pathogen.
INTRODUCTION
Bacterial lipoproteins are surface-exposed proteins, anchored to the cell membrane through a post-translational diacylglyceryl modification, and participate in diverse cellular processes, including nutrient uptake and transport, cell wall remodeling, sporulation, signaling, adhesion, and antibiotic resistance (Chimalapati et al., 2012; Nielsen and Lampen, 1982; Okugawa et al., 2012) . In addition, they can activate host immune response pathways via recognition of the diacylglyceryl motif by Toll-Like Receptor 2 (Blanc et al., 2013) .
Gram-positive lipoproteins contain an N-terminal lipobox within their type II signal peptide sequence, which features an invariant +1 cysteine residue (Buddelmeijer, 2015; Hutchings et al., 2009) . Following export via the general secretory pathway (Sec), the signal peptide is retained within the membrane and a prolipoprotein diacylglyceryl transferase (Lgt) catalyzes the covalent attachment of a membrane phospholipid substrate to the conserved cysteine, forming a thioether linkage (Sankaran and Wu, 1994) . The signal peptide is cleaved by a lipoprotein (type II) signal peptidase (Lsp) (Hayashi et al., 1985) , leaving the mature lipoprotein anchored to the membrane via the lipidmodified N-terminal cysteine (Figure 1 ). Lgt and Lsp are essential in Gram-negative bacteria, but are dispensable in Gram-positive bacteria studied to date, despite the essential nature of many lipoproteins (Widdick et al., 2011) .
Previous methods for studying bacterial lipoproteins rely on radiolabeling with fatty acids, which suffers from low sensitivity and relatively low throughput. Consequently, bioinformatics prediction is commonly used but is restricted to proteins containing a well-defined lipobox motif and requires experimental confirmation (Rahman et al., 2008) . Disruption of lipoprotein processing by genetic inactivation of lgt (Baumgartner et al., 2007) or by inhibition of Lsp by the antibiotic globomycin (Reglier-Poupet et al., 2003) have enabled identification of a small number of lipoproteins, but these approaches lack general applicability. In contrast, metabolic chemical tagging with alkyne-tagged fatty acid analogs provides a potentially global approach to study the lipoproteome, as demonstrated in proof of principle studies in diverse species of Gram-negatives, Gram-positives, and Mycobacteria (Rangan et al., 2010) .
Metabolic tagging takes advantage of the cell's post-translational machinery to incorporate a chemical tag specifically at the site of modification, allowing visualization and identification of a certain class of post-translational modification (PTM) . Typically, an analog of the natural substrate featuring a biologically unobtrusive tag (e.g. azide or alkyne) is used. Attachment of a fluorophore through a highly selective, so-called bio-orthogonal, reaction enables rapid and sensitive detection of labeled proteins, while attachment of an affinity tag allows selective and efficient enrichment of labeled proteins for identification by tandem mass spectrometry (MS/MS)-based proteomic analysis. This approach has been applied to the study of a range of PTMs, including acetylation , myristoylation (Broncel et al., 2015; Charron et al., 2009; Thinon et al., 2014; Wright et al., 2014) , palmitoylation (Charron et al., 2009; Martin et al., 2012) , cholesterylation (Ciepla et al., 2014) , and prenylation (Berry et al., 2010; Charron et al., 2013) . However, metabolic tagging and MS/MS-based identification of the lipoproteome has not previously been applied to a Gram-positive bacterium or to pathogenic bacteria.
Clostridium difficile is a Gram-positive, spore-forming, anaerobe that causes severe gastrointestinal disease. It is highly antibiotic resistant and is the leading cause of hospital-acquired infection (Kuipers and Surawicz, 2008) . C. difficile infection (CDI) typically occurs following broad-spectrum antibiotic treatment, which disrupts the natural gut microbiota and enables colonization (Evans and Safdar, 2015) . C. difficile cells produce two toxins, TcdA and B, which are the major virulence factors (Jank and Aktories, 2008) and lead to symptomatic infection. Spores produced in the gastrointestinal tract of the host during infection are shed in feces , and are responsible for persistence and recurrence of CDI due to their resistance to disinfectants, desiccation, and extreme temperatures (Gerding et al., 2008) . The C. difficile lipoproteome is expected to play an important role in CDI through modulation of host-pathogen interactions, nutrient uptake, and sporulation. For example, the predicted lipoprotein CD630_08730 is a surface-exposed adhesin anticipated to have an important role during colonization (Kovacs-Simon et al., 2014) , while expression of the putative lipoproteins OppA and AppA indirectly inhibits sporulation, suggesting that these proteins may modulate virulence by controlling nutrient availability .
Here we report the first global study of the C. difficile lipoproteome using metabolic tagging and quantitative proteomic profiling. We demonstrate experimentally the lipidation of over 50 lipoproteins in two strains and analyze the effects of mutation of three genes essential for lipoprotein lipidation and proteolytic processing. Furthermore, we describe a sporulation defect in these mutants and identify lipoproteins implicated in sporulation, highlighting the power of this approach for lipoprotein identification and characterization in this important human pathogen.
RESULTS

Alkyne-Tagged Myristate Is an Efficient Probe for C. difficile Lipoproteins
We used metabolic tagging with an alkyne-tagged fatty acid analog, in conjunction with quantitative proteomics, to create a comprehensive profile of the lipoproteome of C. difficile 630 Derm. Lgt enzymes typically exhibit little selectivity with respect to the lipid substrate, accepting saturated or mono-unsaturated fatty acids of 14-20 carbons (Nakayama et al., 2012) . We therefore used a series of alkyne-tagged fatty acid analogs of increasing chain length (C 11 , C 12 , C 13 , C 14 , C 17 , and C 18 ), synthesized following a route previously reported by our group . Exponential cultures of C. difficile 630 were treated with each probe at 25 mM, and incorporation into lipoproteins was assessed by in-gel fluorescence following selective ligation to a multifunctional capture reagent (AzTB) through copper (I)-catalyzed azide-alkyne cycloaddition (CuAAC) as previously described (Broncel et al., 2015) . Ligation to AzTB permits both fluorescent detection, through a TAMRA label, and affinity enrichment of tagged proteins, through a PEG-Biotin label. A clear preference for longer chain lengths was observed ( Figure S1A ) and alkyne-tagged myristic acid (YnMyr) (Figure 2A ) was selected for investigation of optimal feeding concentration. A dose of 10 or 25 mM YnMyr gave the strongest labeling, while a reduction in labeling was seen at concentrations higher than 50 mM, possibly due to limitations of probe solubility ( Figure S1B ). Pronase treatment and western blotting using an anti-lipoteichoic acid (LTA) antibody (Cox et al., 2013) showed that these probes are also incorporated into LTA, an a-D-GlcNAc(1-3)-a-D-GlcNAc glycosyl-phosphate polymer anchored to the cell membrane by a diacylglyceryl anchor (Reid et al., 2012) . Methanol/chloroform precipitation prior to CuAAC effectively removed LTA from the sample, enabling affinity enrichment of labeled proteins on NeutrAvidin resin (Figures S1C and S1D) .
As lipoproteins potentially play an important role in infection, we compared the labeled lipoproteome of strain 630 with a range of clinical isolates of different ribotypes. A broadly similar labeling pattern was observed for most strains with the exception of the evolutionarily divergent strain M120 and the ribotype 027 strain R20291 ), which displayed a subtly different profile to 630 ( Figure 2B ).
Profiling the Lipoproteome of C. difficile 630 Derm
To support lipoproteome profiling, lists of 68 and 62 potential lipoproteins from C. difficile strains 630 and R20291, respectively, were generated using bioinformatics methods (Table S1 ). Broadly conserved putative functions indicated a degree of lipoproteome conservation across these strains, with approximately 1.8% of the proteome predicted to be lipidated.
As genuine protein tagging through modification with YnMyrcontaining phospholipids would be expected to be outcompeted by addition of excess myristate, we implemented a quantitative competition analysis in order to focus our lipoprotein profile on valid substrates for lipidation. When C. difficile 630 Derm (a derivative of 630 amenable to genetic manipulation (Heap et al., 2007) ) was grown in the presence of 0-100 mM myristic acid and 10 mM YnMyr, a myristatedependent reduction in in-gel fluorescence was observed (Figure 2C ). Based on these results, reduction in biotin-NeutrAvidin enrichment of proteins tagged with 10 mM YnMyr was quantified through triplex dimethyl labeling (Boersema et al., 2009; Li et al., 2013) at 0, 50, and 100 mM competing myristic acid. A total of 187 enriched proteins were quantified in all three biological replicates, and 56 proteins showed a highly significant (multiple ANOVA; p % 0.01) reduction in enrichment on competition with an excess of myristic acid (Table S2 and Figure 3A) . Of these, 46 (82%) were predicted to be lipoproteins by bioinformatics analysis, distributed across a range of known or predicted functions (Table 1 and Figure 3B ). Sixty-eight percent of the predicted lipoproteome was identified, representing excellent coverage since not all predicted lipoproteins are expected to be expressed under a single set of experimental conditions. Conversely, it is also possible that a proportion of predicted lipoproteins are not, in fact, genuine substrates for Lgt.
The majority of identified lipoproteins are solute-binding proteins associated with ABC transporters (19), which frequently play an important role in nutrient uptake and are known to be lipidated in other species (Alloing et al., 1994) , alongside uncharacterized proteins (4) or putative lipoproteins (14) of unknown function. CD630_08730, an ABC-type transporter sugar-family extracellular solute-binding protein, was significantly outcompeted by excess myristic acid, providing the first direct evidence that this is a lipoprotein. CD630_08730 has been shown to function as an adhesin and a C. difficile mutant is unable to adhere to Caco-2 cells, whereas the recombinant protein binds directly to cells (Kovacs-Simon et al., 2014) , suggesting that this and other lipoproteins may play important roles in colonization.
We also identified the extracellular chaperones PrsA (CD630_35000) and PrsA2 (CD630_15570) as lipoproteins; PrsA is lipidated in Bacillus subtilis and is essential in a number of bacterial species (Kontinen and Sarvas, 1993) . These proteins have peptidylprolyl isomerase function and form part of the Sec secretion system, assisting in the folding of exported proteins. Their identification is important as the secondary Sec system in C. difficile functions as the major export pathway for the S-Layer Proteins (SLPs), and both Sec systems are essential in C. difficile 630 (Fagan and Fairweather, 2011) . It is probable that one or both C. difficile PrsA proteins play an essential role in the export and folding of the SLPs.
Ten proteins (18%) not predicted to be lipidated by bioinformatics analysis were identified as hits, of which four were predicted to have multiple transmembrane domains and therefore are unlikely to be lipidated by Lgt. We hypothesize that these proteins may show enrichment and myristate-dependent competition due to close association with a lipoprotein or residual-tagged LTA. For example, a calcium-transporting ABC-type transporter ATPase (CD630_16370) was identified in our analysis, and would be expected to be in close association with a solute-binding lipoprotein. Two proteins, CD630_18710 and CD630_19300, have lipoboxes which, in the case of CD630_19300, perfectly match the consensus. CD630_18710 has a predicted signal peptide, but a poorly conserved lipobox, while CD630_19300 has an unusually long signal peptide sequence, neither of which were correctly identified, highlighting the limitations of a purely bioinformatics approach.
Profiling the Lipoproteome of C. difficile R20291 The myristate competition experiment was next applied to C. difficile R20291, an ''epidemic'' strain associated with poor clinical outcomes ) and containing over 230 unique genes compared with strain 630. A total of 110 proteins were quantified in all three biological repeats, 60 of which showed a significant reduction in enrichment (multiple ANOVA; p % 0.01) on competition with excess myristic acid (Table S2 and Figure 3C ), 35 (57%) of which were predicted to be lipoproteins by bioinformatics analysis, as summarized in Figure 3D . The remaining 25 (43%) were not predicted to be lipidated; 5 of these (8% of total) are homologs of predicted lipoproteins in C. difficile 630, including the extracellular chaperones PrsA and PrsA2 and the ABC-type transporter solute-binding proteins SsuA and AppA. In all cases the bioinformatics predictions failed due to incorrect assignment of translation start codons during annotation. The remaining 20 (33%) appear to be background proteins; this level of background enrichment may reflect a need for further optimization of this method for application to R20291. Overall, this result demonstrates that lipoproteins show a high degree of conservation, both functionally and at a primary sequence level, between these two C. difficile strains.
Lgt Catalyzes Lipidation in C. difficile C. difficile 630 encodes a single lgt gene (CD630_26590). In a 630 Derm lgt::erm mutant (see Supplemental Information) an almost complete loss of metabolic tagging was observed by ingel fluorescence, while complementation with a plasmid expressing lgt restored the wild-type labeling pattern ( Figures  4A and 4C ). The lgt mutant and wild-type strains had similar growth rates in exponential phase as measured by optical density (data not shown). Comparison of the lipoproteomes of 630 Derm and lgt::erm by quantitative proteomics identified a total of 210 proteins quantified in all three repeats, of which 43 proteins showed significantly increased enrichment in 630 Derm over lgt::erm (p % 0.05), and 41 were predicted lipoproteins (Tables 1 and S3 ; Figures 4D and 4E ). All but one of the predicted lipoproteins that were significantly enriched in 630 Derm over lgt::erm showed a significant reduction in enrichment on competition with YnMyr and myristic acid, demonstrating unequivocally that these proteins are labeled by YnMyr in an Lgtdependent manner and are therefore genuine lipoproteins.
The usefulness of the labeling approach is demonstrated by the identification of CD603_18710, a protein not predicted to be lipidated, but significantly enriched through tagging in 630 Derm compared with lgt::erm. We verified lipidation by inducible expression of a C-terminal His 6 -tagged protein in both 630 Derm and lgt::erm backgrounds. On induction, CD630_18710-His 6 was highly expressed in both strains, and tagging with YnMyr occurred in an Lgt-dependent manner ( Figure S2C ). Although we have not identified the site of modification, these multiple lines of evidence strongly suggest that lipidation of CD630_18710 occurs via the canonical pathway despite its non-consensus lipobox.
In other bacterial species, lgt mutants can shed lipoproteins into the media at an increased level relative to the wild-type, a phenotype previously used to identify lipoproteins indirectly (Baumgartner et al., 2007; Pribyl et al., 2014) . In C. difficile, an increase in the amount of protein shed was observed for lgt::erm, relative to 630 Derm ( Figure 5A ). Western blotting revealed that the SLPs Cwp66 and LMW-SLP were also shed at an increased rate by lgt::erm ( Figure S5A ). We further identified and quantified shed proteins by proteomic analysis, normalized to total protein recovered; 164 proteins were quantified (Figures 5B and S5; Table S4 ) and, as anticipated, 23 of 24 proteins shed into the media at a significantly (p % 0.05) increased level by lgt::erm relative to 630 Derm were lipoproteins (Table 1 and Figure 5C ). Only 50% of lipoproteins identified through tagging could be detected by this untargeted method, demonstrating a further advantage of enrichment through metabolic chemical tagging over this traditional method for lipoprotein identification.
Two Functional Lipoprotein Signal Peptidases Operate in C. difficile C. difficile 630 encodes two potential lsp genes, CD630_25970 (lspA) and CD630_19030 (lspA2). The existence of two lspA genes is highly unusual, but both are conserved across all C. difficile strains sequenced to date. Although some other Gram-positive bacteria encode more than one lsp gene, the accessory Lsp may not be functional in all cases (Kovacs-Simon et al., 2011) . The existence of two functional LspAs was investigated by insertionally inactivating either lspA or lspA2 in C. difficile 630 Derm; inactivation of either lspA or lspA2 did not affect exponential growth rates (data not shown). The ingel fluorescence pattern for lspA::erm showed a number of lipoprotein bands at higher apparent molecular weight (MW) (Figure 4A) , which we hypothesize is due to the retention of the type II signal peptide. Inactivation of lspA2, in contrast, resulted in a general reduction in labeling intensity, but relatively few bands shifted to a higher MW. Constitutive expression of lspA or lspA2 in trans largely restored the wild-type pattern. These data are consistent with LspA processing the majority of lipoproteins, including a number of unique substrates; in contrast, LspA2 may not have unique substrates.
Since double knockouts have, until recently, been very challenging to produce in C. difficile, we used a globomycin, a cyclic peptide antibiotic and a specific inhibitor of Escherichia coli LspA (Hussain et al., 1980) , to further unravel the activity and potential functional redundancy of LspA and LspA2. 630 Derm, lspA::erm, and lspA2::erm were grown in the presence 100 mg ml À1 globomycin, and the effect on lipoprotein processing was investigated by labeling with 25 mM YnMyr. Treatment with globomycin had no effect on bacterial growth (data not shown). On globomycin treatment, 630 Derm displayed a remarkably similar labeling pattern to untreated lspA::erm, while lspA::erm, which possesses only LspA2, showed no significant changes. In contrast, lspA2::erm showed dramatic changes when treated with globomycin, with a global shift to higher apparent MWs of YnMyrtagged lipoproteins ( Figure 4B ). LspA is thus strongly inhibited by 100 mg ml À1 globomycin, while LspA2 is not, a conclusion consistent with the lower sequence homology of E. coli K12 LspA to C. difficile LspA2, compared with C. difficile LspA. Globomycin treatment results in an lspA::erm-like phenotype for the parental strain and a doubly inactivated phenotype for lspA2::erm, while lspA::erm is unaffected by globomycin treatment. Based on these data, we hypothesize that inactivation of both LspAs (lspA2::erm + globomycin) results in a global retention of signal peptides and a corresponding migration of labeled lipoproteins at a higher MW that is not observed for individual inactivation of either LspA, strongly suggesting that both LspA and LspA2 have type II signal peptidase activity. A quantitative lipoproteome analysis between lspA::erm, lspA2::erm, and 630 Derm was performed; the majority of the 46 predicted lipoproteins quantified showed no significant change in enrichment between the three strains (p % 0.01), suggesting that the changes in the in-gel fluorescence band pattern are due to retention of type II signal peptides ( Figure S3 and Table S4 ). An unexpected increase in shedding of proteins into the media was also observed for lspA::erm and lspA2::erm, relative to 630 Derm (Figures 5A and S4) . A quantitative proteomic comparison between the proteins shed by these mutants revealed that those shed at a significantly (p % 0.05) increased level by the lsp mutants were not lipoproteins (Table S5) .
Disrupting Lipoprotein Biogenesis Reduces the Formation of Heat-Resistant Spores
Spo0A (CD630_12140) is a transcription factor that acts as the master control regulator for the initiation of sporulation. When activated by phosphorylation Spo0A$P binds directly to the DNA upstream of its targets, activating early sporulation genes and repressing those required for stationary phase growth . Mutants in spo0A are defective in sporulation (Underwood et al., 2009 ) and unable to persist in mice or transmit between animals (Deakin et al., 2012) . Incomplete lipoprotein processing in C. difficile 630 Derm resulted in a significant (p % 0.05) decrease in Spo0A level for lspA::erm and lspA2::erm of 2.5-and 4.3-fold, respectively, and a 2.2-fold reduction for lgt::erm, which approached significance (p % 0.06), assessed by quantitative proteomic analysis of the global proteomes ( Figure 6A ; Tables S3 and S4 ).
The lipoprotein biogenesis mutants produced a similar number of total colony-forming units (CFUs) per milliliter of culture after 16 hr and at all further time points. However, lgt::erm and lspA::erm exhibited a striking delay in the production of heat-resistant spores, and significantly fewer heat-resistant CFUs (p % 0.05 at 48 hr; p % 0.01 thereafter) were formed than by the parental strain, while lspA2::erm did not form spores under these conditions ( Figure 6B ), a result also confirmed by phase-contrast microscopy ( Figure S6 ). The lack of characteristic phase bright spores for lgt::erm, lspA::erm, and lspA2::erm indicates a profound defect in sporulation.
Spo0A Regulation of Lipoprotein Expression in C. difficile 630 Derm
The observed reduction in Spo0A levels in the lgt::erm, lspA::erm, and lspA2::erm mutant strains may in turn affect transcription of Spo0A-regulated genes that encode lipoproteins. In the absence of Spo0A, a number of lipoproteins showed changes in production or lipidation level as assessed by in-gel fluorescence, implying regulation by Spo0A (Figure 6C) . To further investigate potential effects on the lipoproteome, and to identify sporulation-associated lipoproteins, a quantitative lipoproteome analysis was performed between spo0A::erm and the parental strain, 630 Derm. Forty-six of the 168 proteins quantified were lipoproteins, and an additional nine previously showed significantly reduced enrichment on competition between YnMyr and excess myristate. Four ABC-type transporter solute-binding proteins were significantly reduced in enrichment in spo0A::erm, relative to the parental strain, implying positive regulation by Spo0A: CD630_07500, ModA (both p % 0.05), SsuA and OppA (both p % 0.01) ( Figure 6D and Table S6 ). ssuA has an upstream Spo0A binding sequence (0A box) and is under direct positive regulation by Spo0A (Rosenbusch et al., 2012) , while CD630_07500, modA and oppA are more likely to be indirectly Spo0A-regulated.
We conducted a quantitative comparison between the global proteome of these strains ( Figure S7 and Table S6 ) and observed a highly significant (p % 0.005) reduction in expression of both SsuA (5-fold) and OppA (2-fold) in the insoluble sub-proteome of spo0A::erm, confirming that the reduction in enrichment of SsuA and OppA was due to a reduction in protein level. In addition, our data correlate well with known phenotypes of spo0A::erm and with previous proteomic and transcriptomic comparisons with 630 Derm (Fimlaid et al., 2013 ; Pettit et al., 2014). Finally, two lipoproteins, the ABC-type transporter solutebinding protein SsuA2 and CD630_19300, a highly conserved metallo-b-lactamase, showed significantly (p % 0.05) increased enrichment in spo0A::erm ( Figure 6D ). As neither gene features an upstream 0A box, they appear to be indirectly downregulated by Spo0A, suggesting repression during sporulation; however, the increase in SsuA2 may be an adaption to compensate for reduced SsuA.
DISCUSSION
Here we report the use of an alkyne-tagged analog of myristic acid (YnMyr) to profile the lipoproteome of the Gram-positive pathogen C. difficile. Competition between YnMyr and an excess of the natural lipid, in conjunction with quantitative proteomic analyses, generated a robust profile of the lipoproteome for 630 Derm and R20291. This is the first description of the lipoproteome of a Gram-positive bacterium, providing direct biochemical verification of lipidation for the majority of the predicted lipoproteome. YnMyr labeling was shown to occur in an Lgt-dependent manner, further validating our results. In total, we identified 74% of the predicted C. difficile 630 Derm lipoproteome, and an additional two novel lipoproteins (Figure 5D ; Tables 1 and S7 ). Alignment of the lipoboxes from the C. difficile 630 Derm lipoproteins identified in this study revealed that the lipobox differs subtly from the consensus, with valine or threonine equally conserved in the À2 position and a more variable À3 position. In contrast, leucine is conserved in the À3 position in B. subtilis, while the À2 position is less conserved. In both species, glycine is favored in the À1 position ( Figure S2D ).
The presence of two active type II signal peptidases (LspA and LspA2) has never been reported in a Gram-positive bacterium. Utilizing genetic and chemical inactivation of the Lsps, combined with metabolic tagging with YnMyr and quantitative proteomic analysis, we have demonstrated the activity of both LspA and LspA2 in C. difficile. The lipoprotein biogenesis mutants expressed reduced levels of Spo0A and display a severe defect in formation of heat-resistant spores, demonstrating that complete processing of the lipoproteome is required for efficient sporulation and implicating lipoproteins in persistence and transmission of this important pathogen. A quantitative comparison between the lipoproteome of the asporogenous mutant spo0A::erm and the parental strain revealed significantly reduced enrichment of four ABC-transport solute-binding lipoproteins in the spo0A::erm mutant, indicative of regulation by Spo0A, implicating these proteins in the initiation of sporulation. We suggest that these lipoproteins may form part of a nutrientsensing feedback mechanism, acting to confirm low nutrient availability before committing to sporulation.
The reduction in Spo0A levels observed in the lgt::erm, lspA::erm, and lspA2::erm mutants indicates that the lipoproteins involved in this phenotype act upstream of Spo0A. We identified a number of other lipoproteins that contain other sporulation-associated domains, including a homolog of the sporulation-associated B. subtilis lipoprotein Med (CD630_05690). Med is required for the activation of KinD in B. subtilis, which initiates a phosphorelay culminating in activation of Spo0A (Banse et al., 2011) . It is possible that the C. difficile Med homolog is required for full activity of the transmembrane kinases CD630_14920 and CD630_24920, which act directly on Spo0A (Underwood et al., 2009) . As Spo0A$P activates its own expression, a reduction in kinase activity would lead to reduced Spo0A expression, providing an explanation for this observation. Interestingly, in B. subtilis Lgt is required for germination, but not for sporulation (Igarashi et al., 2004) , revealing further differences between the developmental pathways of these two spore-forming bacteria.
Pfam analysis of the uncharacterized lipoproteins revealed lipoproteins containing germane domains homologous to that found in the B. subtilis lipoprotein GerM. GerM is believed to be involved in peptidoglycan synthesis during spore development and is required for efficient spore formation and germination (Sammons et al., 1987; Slynn et al., 1994) . The germane domain-containing lipoproteins in C. difficile may function in both sporulation and germination, and it is possible that the sporulation defect observed results from a combination of altered activity of the Med and Germane homologs. While our data do not rule out roles for lipoproteins in germination, it is highly likely that the lipoproteome plays an important role in sporulation in C. difficile.
In conclusion, we have demonstrated that the combination of chemical tagging of lipidation with quantitative proteomics is a powerful approach for experimental exploration and definition of the lipoproteome in a Gram-positive human pathogen.
SIGNIFICANCE
Gram-positive lipoproteins are anchored to the cell surface by an N-terminal S-diacylglyceryl modification. Despite the non-essential nature of the Gram-positive lipoprotein biogenesis pathway, they are frequently essential for bacterial survival and pathogenesis. The Gram-positive pathogen C. difficile is a leading cause of hospital-acquired infection; spores are the transmissible agent and are critical for its persistence in the environment. C. difficile lipoproteins have been found to play important roles in colonization and transmission; however, its lipoproteome remained poorly characterized.
Here we report the application of quantitative lipoproteomics to C. difficile, providing the first system-wide comparative tool to address the impact of conventional genetic and pharmacological disruption of the lipoproteome, enabling the unbiased confirmation or revision of lipoprotein assignments from bioinformatics. The usefulness of our approach is demonstrated in the first comprehensive map of the C. difficile lipoproteome, including that of a virulent clinical isolate. This approach provides further insights into lipoprotein biogenesis in C. difficile, demonstrating the activity of an accessory type II signal peptidase, LspA2. This study also provides the first evidence for the importance of lipoprotein biogenesis in sporulation, implicating lipoproteins in the transmission of this pathogen. We anticipate that the experimental framework presented here will find wide application both in C. difficile and in Gram-positive pathogens in general. 
EXPERIMENTAL PROCEDURES
The synthesis of the alkyne-tagged fatty acid probes, ClosTron mutagenesis, plasmid construction, and lists of all plasmids and primers used in this study are described in the Supplemental Information. Globomycin and the dimethyllabeling reagents were purchased from Sigma Aldrich and used without further purification. NeutrAvidin agarose beads were purchased from Invitrogen.
Bacterial Culture All C. difficile and E. coli strains used in this study are detailed in the Supplemental Information. C. difficile was routinely cultured on BHIS agar composed of 3.7% BHI (Oxoid, CM1135), 0.5% yeast extract (BD Bacto, 211713), 0.1% Lcysteine (Sigma Aldrich), 1.5% Agar (BD Bacto, 214030) . Liquid cultures for metabolic labeling were performed in TY broth composed of 3% Bacto Tryptose (BD Bacto, 211713) and 2% yeast extract (BD Bacto, 210929) . Liquid cultures for genetic manipulation and phenotypic assays (where indicated) were performed in BHIS broth composed of 3.7% BHI (Oxoid, CM1135), 0.5% yeast extract (BD Bacto, 210929), 0.1% L-cysteine (Sigma Aldrich). All cultures were grown at 37 C under a reducing anaerobic atmosphere (10% CO 2 , 10% H 2 , and 80% N 2 ).
Metabolic Tagging
Overnight cultures of C. difficile were subcultured to an optical density (OD) 600 of 0.05. For competition experiments, the subculture was immediately treated with myristic acid in DMSO to the desired concentration. Synchronously growing subcultures were allowed to grow to early exponential phase (OD 600 z 0.3) before being treated with an alkyne-tagged fatty acid analog in DMSO; the probe and the concentration varied between experiments, with the final concentration of DMSO for each culture fixed at 1% (v/v). Typically, 10 or 25 mM YnMyr was used for metabolic labeling, and the cultures were grown to stationary phase over 6-8 hr, before cell lysis.
Proteomic Analysis
Peptide mixtures were separated on an Easy-Nano UHPLC (ultra-high-performance liquid chromatography; Thermo Scientific) equipped with an Acclaim Pepmap 100 pre-column and an EASY-Spray 50 cm 3 75 mm Pepmap C 18 column (Thermo Scientific) eluting using a gradient of 2% acetonitrile, 0.1% trifluoroacetic acid (TFA), to 98% acetonitrile, 0.1% TFA in water at a flow rate of 250 nl min À1 , over 2 hr. The nano-UHPLC was connected directly to a Q-Exactive Quadrupole-Orbitrap mass spectrometer (Thermo Scientific) for MS/MS analysis, via a heated EASY-Spray source (Thermo Scientific) operated at a spray voltage of 1.7 kV. The Q-Exactive was run in positive ion mode, using data-dependent (Top 10) acquisition with an isolation window of 3.0 m/z. Ions were fragmented by higher-energy collisional dissociation with normalized collision energies of 25 W; the ion target value was set to 10 6 for MS and 10 5 for MS/MS.
Data Analysis
Thermo.RAW files generated by Xcalibur were processed using MaxQuant 1.3.0.5 (Cox and Mann, 2008) , searching against the corresponding database using the Andromeda search engine (Cox et al., 2011) . All databases to search against were created by extracting the complete proteome of the relevant C. difficile strain from UniProt (630 and R20291, both 08/2013); common contaminants were included in the search. Methionine oxidation and N-terminal acetylation were set as variable modifications and cysteine S-carbamidomethylation as a fixed modification. For dimethyl-based quantification, the multiplicity and labels were set depending on the experiment, allowing a maximum of three labeled amino acids per peptide. A total of five modifications per peptide, two missed cleavages, and a maximum charge of +7 was allowed. A false discovery rate of 0.01 for peptides, proteins, and sites was used for identification; the minimum peptide length allowed was seven amino acids. For protein identification, the minimum number of peptides and razor + unique peptides allowed was set to 1; both razor and unique peptides were used for (Tables S3 and S4 ). Values are the average of three biological repeats, ±SD; *p % 0.06, **p % 0.05. (B) Sporulation dynamics for the lipoprotein biogenesis pathway mutants; the asporogenous mutant spo0A::erm was included as a negative control. All three lipoprotein biogenesis mutants showed a significant reduction in sporulation efficiency. The zero time point was taken at the onset of the stationary phase. Values are the average for technical triplicates of biological duplicates (six values), ±SD. Values of zero were artificially set to 1 to allow plotting on a log 10 scale, the limit of detection (100 CFU ml quantification. Only proteins that were quantified in all biological replicates were used for further analysis. Data were filtered to remove common contaminants, normalized to the median, and statistical testing was performed using Perseus 1.4.0.8. Protein annotations were imported from the UniProt and Pfam databases, and the data were exported to Microsoft Excel 2010 for further analysis. The mass spectrometry proteomics data have been deposited in the ProteomeXchange Consortium (Vizcaino et al., 2014) via the PRIDE partner repository with the dataset identifier PRIDE: PXD002426.
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